CJC-1295 With DAC
CJC-1295 With DAC from the Nexus Growth Hormone Secretagogues catalog, supplied for controlled in-vitro research workflows.
Ships from the US with tracking.
Catalog active: Catalog pricing is active. Live warehouse counts are not published.
- Lot-specific COA
- HPLC + MS fields
- Batch archived
For in-vitro research use only. Not for human consumption.
CJC-1295 with DAC is a synthetic GHRH analog conjugated with a Drug Affinity Complex that covalently binds serum albumin, dramatically extending its research half-life. This produces sustained GH elevation rather than the pulsatile pattern seen with the non-DAC version.
No sequence is listed in the current catalog record for this product.
- CAS
- 446262-90-4
- MW
- 3647.30 Da (with DAC conjugate)
- Sequence
- Not listed
- Half-life
- Discussed in research notes
- Formula
- C165H269N47O46
- Purity
- 99.71%
- Form
- Lyophilized powder
- Class
- Long-Acting GHRH Analog
The dossier.
Compound Overview
CJC-1295 with DAC is a synthetic GHRH analog attached to a Drug Affinity Complex designed for covalent serum albumin binding. In laboratory research contexts, that albumin-binding modification dramatically extends the compound's research half-life and supports sustained GH elevation rather than the pulsatile pattern associated with the non-DAC form.
Research Background & Published Literature
DAC technology was created as a tool for studying prolonged GHRH receptor stimulation. Published pharmacokinetic research has characterized its extended duration of action relative to native GHRH and Mod GRF 1-29, making it relevant to controlled protocols that require sustained rather than pulsatile GH signaling.
Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:
Storage, Handling & Stability Guidelines
Use the applicable lot/source record for storage of unopened material. Any diluent selection, preparation, temperature, aliquoting, or post-reconstitution hold conditions must be established by a qualified laboratory under a validated SOP; this page does not establish a stability window.
- Limit ambient-temperature exposure during handling to help preserve compound integrity.
- Reseal vials promptly after each withdrawal to reduce moisture exposure.
- Use appropriate personal protective equipment and follow institutional chemical safety protocols at all times.
- For traceability, label all aliquots with compound name, concentration, reconstitution date, and operator initials.
Quality Assurance & Lab Verification
A finalized public Certificate of Analysis is available for this catalog item. Review the public COA for the applicable lot. Lot-specific identifiers, assay values, and methods are maintained in that record and are not repeated in this product dossier.
Shipping
Orders ship within the United States via USPS; international orders are not accepted. Laboratories should follow their validated SOP together with any handling fields published for the represented product or lot; no universal prepared-solution condition is inferred here.
Compound details.
- CAS Number
- 446262-90-4
- Molecular Weight
- 3647.30 Da (with DAC conjugate)
- Molecular Formula
- C₁₆₅H₂₆₉N₄₇O₄₆
- Class
- Long-Acting GHRH Analog
Research context.
The DAC technology was developed to study prolonged GHRH receptor stimulation. Published pharmacokinetic studies have characterized its extended duration of action compared to native GHRH and Mod GRF 1-29. Useful for research protocols requiring sustained rather than pulsatile GH signaling.
Verification standard.
Certificate information is lot-specific. A finalized public record shows only the methods, fields, and results present for that named lot. A pending certificate state exposes no assay values and must not be interpreted as analytical verification. Review Nexus lab verification.
Analytical record.
- Reported HPLC purity
- 99.71%
- Retention time
- 14.00 min
- Observed mass
- 3647.17 Da
- Batch
- APX-2026-0409-C
The normalized Certificate of Analysis publishes only the lot-specific fields represented in the public record. It is not an originating laboratory report or raw instrument file.
View certificate of analysis - batch APX-2026-0409-C- Sequence
- Not listed
- Model preview
- Unavailable
Molecular model preview is unavailable for this catalog record.
The chemistry.
30-amino acid GHRH analog conjugated with a Drug Affinity Complex (DAC) for albumin binding
Technical specifications.
- Product Name: CJC-1295 with DAC
- Classification: Long-Acting GHRH Analog
- Structural Description: 30-amino acid GHRH analog conjugated with a Drug Affinity Complex (DAC) for albumin binding
- CAS Number: 446262-90-4
- Molecular Weight: 3647.30 Da (with DAC conjugate)
- Purity: ≥99% (verified by HPLC and Mass Spectrometry)
- Physical Form: Lyophilized (freeze-dried) powder
- Intended Use: In-vitro research use only — not for human consumption
Related research compounds
Comparable catalog records with published variants and certificate status.
- Growth Hormone SecretagoguesVerified batchCJC-1295 Without DACPriceFrom $23.99Formats3 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 863288-34-0View product - Growth Hormone SecretagoguesVerified batchIpamorelinPriceFrom $25.99Formats3 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 170851-70-4View product - Growth Hormone SecretagoguesVerified batchTesamorelinPriceFrom $25.99Formats4 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 218949-48-5View product - Growth Hormone SecretagoguesVerified batchSermorelin AcetatePriceFrom $32.99Formats4 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 86168-78-7View product - Growth Hormone SecretagoguesVerified batchGHRP-2 AcetatePriceFrom $20.99Formats2 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 158861-67-7View product
Research notes.
CJC-1295 With DAC research FAQ.
What is CJC-1295 With DAC used for in research?
CJC-1295 With DAC is supplied for controlled in-vitro research workflows in the Growth Hormone Secretagogues category. It is not labeled for human or veterinary use.
Does CJC-1295 With DAC have a finalized analytical record?
CJC-1295 With DAC has a finalized Nexus Lab Verified record that reports 99.71% HPLC area-percent purity for the represented batch. Other fields are shown only where present.
Which CJC-1295 With DAC variants are published?
Published Nexus variants include 2mg, 5mg, 10mg.
Does CJC-1295 With DAC include a COA?
Yes. The current Nexus record links CJC-1295 With DAC to finalized batch APX-2026-0409-C.